Supraclavicular lymph node tuberculosis presenting with immune thrombocytopenic purpura

Hua Lu, Yong-ren Wang, Ou Ji, Wei Xu, Jian-fu Zhang, Qin-he Fan, Jian-yong LiChinese 2007 · DOI

Abstract

Tuberculosis (TB) differs from many other infectious maladies in having particular social and geographic distributions. The disease was under control in developed nations and being brought under control in developing countries, as in China. TB has now been recognized as a public health threat and the incidence of TB is steadily rising. Though a lot of various hematological disorders have been described in TB, like anemia, leukocytosis and, the most frequently cited, pancytopenia, immune thrombocytopenic purpura (ITP) is extremely rare. When thrombocytopenia occurs in TB, it happens most commonly via non-immune pathways, as typically described in the context of pancytopenia that develops secondary to tuberculous granulomatous infiltration of the bone marrow, but a causal relationship between TB and immune thrombocytopenia is extraordinarily rare. Here we report a case of supraclavicular lymph node tuberculosis combined with ITP. CASE REPORT A 48-year-old man was admitted in July 2005 with a history of weight loss up to 7.5 kg within the past six months, combined with night sweats, and occasional general malaise. Physical examination revealed a blood pressure of 120/80 mmHg, oral temperature 37.8°C, intensive and extensive petechiae distributed over the lower extremities and also scattered over the upper extremities. Two enlarged supraclavicular lymph nodes were detected on the right side, both about 1.0 cm × 1.5 cm sized, tenacious, movable, without tenderness, the lower margin of the spleen was palpable and no hepatomegaly was detected. Laboratory findings were as follows: white blood cells 8.6×109/L, hemoglobin 89 g/L, platelet 6×109/L. Bone marrow examination showed an increased cellularity of all cell types with normal maturation of erythroid and myeloid precursors. An increased number of megakaryocytes, 109 per slide, with normal morphology were observed: granular megakaryocytes predominating (98/slide), mature megakaryocytes (9/slide), and thrombocytopoiteic megakaryocytes (2/slide). Purified protein derivative test was ++ and the erythrocyte sedimentation rate was 46 mm/h. C-reactive protein was 1.76 mg/L, anti-nuclear antibody (ANA) was positive (nucleolus type). Other tests were normal. Chest X-ray and B-type ultrasound examination for the abdominal organs (liver, gallbladder, pancreas and spleen) and gastroscopy were all normal; but CT scanning detected enlarged abdominal lymph nodes, with the largest one measuring 3 cm × 2 cm (Fig. 1). Partial portions of the lymph nodes were conglomerated.Fig. 1.: CT scamming shows the enlarged abdominal lymph nodes (arrow).The patient was treated with 10 mg dexamethasone intravenously daily. Seven days later, the blood routine test showed a platelet 76×109/L. And a right supraclavicular lymph node biopsy showed a caseating granuloma (Fig. 2). The patient was then started on three anti-TB drugs (rifampicin 450 mg, isoniazid 300 mg, pyrazinamide 1 g) orally daily and corticosteroid was discontinue gradually. The platelet count showed a rapid recovery in a short time. The patient undergoing anti-TB therapy was followed up at 9 months when the platelet count was in the normal range.Fig. 2.: Supraclavicular lymph node biopsy showed necrotizing lymphadenitis with caseating granulomas and inflammatory cells (HE staining). A: original magnification×100. B: original magnification×400.DISCUSSION ITP classically occurs in two subtypes; idiopathic thrombocytopenic purpura and secondary thrombocytopenic purpura which includes systemic lupus erythematosus and lymphoproliferative disorders. However, ITP induced by tuberculosis is rare. The cases responded to glucocorticosteroid therapywith the platelet count increasing to different levels;1-4 the dosage of glucocorticosteroid, which was used for a short time, was 1 mg·–1·d–1 and 10-20 mg/day of methylprednisolone and dexamethasone respectively. However, glucocorticoid treatment was not successful to some cases;5,6 They responded to anti-tuberculosis therapy. If TB and ITP were diagnosed simultaneously, both anti-TB and glucocorticosteroid should be used in order to rapidly increase the platelet level. When patients with ITP induced by TB faced vital thrombocytopenia, if economically possible, intravenous immunoglobulin (IVIG) injection was a better choice because it avoided aggravating the TB condition. Though valuable information regarding clinical data, specific treatment were available in the literature, post-treatment laboratory values, and long-term follow-up information was not available in many reports. The absence of recurrent thrombocytopenia after the withdrawal of corticosteroids and/or IVIG in all cases, and the poor response to immunomodulating therapies alone in most of the patients strongly support the etiologic role of TB in producing ITP and reinforces the need for anti-tuberculosis therapy in patients with TB-related ITP. The existence of platelet antigen specific antibody or platelet membrane IgG supports the diagnosis of TB-induced ITP,7,8 and the excellent response to IVIG treatment also sustains this diagnosis.1,7 However, as highlighted in the American Society for Hematology's 1996 and British Hematology of Society's 2003 guidelines for the diagnosis and management of ITP,9 the absence of anti-platelet antibodies in no way invalidates the diagnosis of ITP. In fact, anti-platelet antibodies are labeled as an “unnecessary” test for the routine evaluation to ITP. TB-induced ITP is seen at all ages but is more common after the 3rd decade. Pulmonary TB was the most common clinical presentation and occurred in 33% of the patients, followed by 19% with either disseminated TB or lymphadenitis. Early in the course of disease there is a relatively mild thrombocytopenia, 81% of patients presented with a platelet count of less than 20×109/L and 24% of patients presented with a platelet count of 5×109/L. In lymphadenitis TB patients, the platelet count is slightly lower than normal. When lymphadenopathy occurs in patients with a low platelet count, a lymph node biopsy should be done promptly. Otherwise, treatment may be focused only on glucocorticosteroid for ITP and neglect anti-TB therapy leading to a spread of tuberculosis. In this case, prompt diagnosis by lymph node biopsy and rapid recovery of the platelet count following treatment with dexamethasone and anti-TB are the key step in the treatment. As the incidence of TB is gradually increasing and TB can induce a variety of hematological abnormalities, we should consider TB as one cause in the etiology of ITP. In order to explain the pathological mechanism of TB-related ITP, further investigation is necessary.
BibTeX
@inproceedings{lu2007supraclavicular,
  author = {Hua Lu and Yong-ren WANG and Ou Ji and Wei Xu and Jian-fu ZHANG and Qin-he Fan and Jian-yong LI},
  title = {{Supraclavicular lymph node tuberculosis presenting with immune thrombocytopenic purpura}},
  booktitle = {Chinese},
  year = {2007},
  doi = {10.1097/00029330-200710010-00019},
}

Loading related content...

Figure